Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Deferred Taxes (2016 - 2018)

China Pharma Holdings' Deferred Taxes history spans 9 years, with the latest figure at -$1195.0 for Q4 2018.

  • For Q4 2018, Deferred Taxes fell 103.91% year-over-year to -$1195.0; the TTM value through Dec 2018 reached $68419.0, down 44.21%, while the annual FY2018 figure was $68419.0, 44.21% down from the prior year.
  • Deferred Taxes reached -$1195.0 in Q4 2018 per CPHI's latest filing, down from $21039.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $421825.0 in Q3 2015 to a low of -$1195.0 in Q4 2018.
  • Average Deferred Taxes over 5 years is $58385.9, with a median of $21039.0 recorded in 2018.
  • Peak YoY movement for Deferred Taxes: skyrocketed 2095.29% in 2015, then plummeted 103.91% in 2018.
  • A 5-year view of Deferred Taxes shows it stood at $19284.0 in 2014, then surged by 2087.44% to $421825.0 in 2015, then tumbled by 42.36% to $243131.0 in 2016, then plummeted by 87.45% to $30525.0 in 2017, then plummeted by 103.91% to -$1195.0 in 2018.
  • Per Business Quant, the three most recent readings for CPHI's Deferred Taxes are -$1195.0 (Q4 2018), $21039.0 (Q3 2018), and $22590.0 (Q2 2018).